Insmed Inc (INSM)
25.55
-0.11
(-0.43%)
USD |
NASDAQ |
May 03, 16:00
25.55
0.00 (0.00%)
After-Hours: 20:00
Insmed 1 Year Total Returns (Daily): 29.04% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 29.04% |
| May 02, 2024 | 33.30% |
| May 01, 2024 | 26.87% |
| April 30, 2024 | 26.77% |
| April 29, 2024 | 28.21% |
| April 26, 2024 | 28.10% |
| April 25, 2024 | 32.27% |
| April 24, 2024 | 36.49% |
| April 23, 2024 | 38.69% |
| April 22, 2024 | 32.33% |
| April 19, 2024 | 35.87% |
| April 18, 2024 | 40.67% |
| April 17, 2024 | 46.34% |
| April 16, 2024 | 56.12% |
| April 15, 2024 | 60.12% |
| April 12, 2024 | 63.96% |
| April 11, 2024 | 69.29% |
| April 10, 2024 | 69.09% |
| April 09, 2024 | 66.43% |
| April 08, 2024 | 67.02% |
| April 05, 2024 | 68.25% |
| April 04, 2024 | 63.06% |
| April 03, 2024 | 59.36% |
| April 02, 2024 | 54.25% |
| April 01, 2024 | 56.72% |
| Date | Value |
|---|---|
| March 28, 2024 | 61.49% |
| March 27, 2024 | 58.47% |
| March 26, 2024 | 64.16% |
| March 25, 2024 | 64.03% |
| March 22, 2024 | 62.55% |
| March 21, 2024 | 56.04% |
| March 20, 2024 | 56.17% |
| March 19, 2024 | 50.00% |
| March 18, 2024 | 50.06% |
| March 15, 2024 | 43.93% |
| March 14, 2024 | 43.61% |
| March 13, 2024 | 51.97% |
| March 12, 2024 | 51.89% |
| March 11, 2024 | 50.61% |
| March 08, 2024 | 41.87% |
| March 07, 2024 | 40.32% |
| March 06, 2024 | 36.20% |
| March 05, 2024 | 35.05% |
| March 04, 2024 | 37.23% |
| March 01, 2024 | 38.64% |
| February 29, 2024 | 36.02% |
| February 28, 2024 | 37.54% |
| February 27, 2024 | 45.50% |
| February 26, 2024 | 43.25% |
| February 23, 2024 | 33.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-51.68%
Minimum
Mar 23 2020
162.7%
Maximum
Mar 22 2021
8.02%
Average
-2.45%
Median
Nov 05 2021
1 Year Total Returns (Daily) Benchmarks
| NeuroMetrix Inc | -49.29% |
| Intra-Cellular Therapies Inc | 8.77% |
| Rhythm Pharmaceuticals Inc | 136.3% |
| Amylyx Pharmaceuticals Inc | -92.77% |
| AN2 Therapeutics Inc | -55.71% |